Pimentel, F. F., Tiezzi, D. G., Andrade, J. M. de, Gonçalves, J., Cardoso, A. C. F., Castilho, V. C., … Toledo, J. S. de. (2021). SYNERGISTIC MECHANISMS OF ACTION: COMPARISON OF ADCC AND SIGNALING PATHWAYS INHIBITION BY TRASTUZUMAB BIOSIMILAR OR ORIGINATOR TRASTUZUMAB IN COMBINATION WITH PERTUZUMAB IN HER2+ BREAST CANCER CELL LINES. Mastology, 31, 9. Recuperado de https://revistamastology.emnuvens.com.br/revista/article/view/981